comparemela.com

Latest Breaking News On - Consumer health company - Page 3 : comparemela.com

Johnson & Johnson : Guidance Press Release with attachments -Today at 09:52 am

FOR IMMEDIATE RELEASE Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation .

Jake sargentJoaquin duatoJessica mooreConsumer health companyJohnson consumer healthKenvue incConsumer healthExchange commissionCompany consumer healthJohnson announces updated financialsKenvue separationSales growthOperational sales growthAdjusted operational sales growthReported earnings per shareAdjusted operational

Johnson & Johnson : Final - JNJ Guidance Webcast -Today at 09:52 am

Johnson & Johnson Updated Financials & 2023 Guidance August 30, 2023 Cautionary Note on Forward-looking Statements .

Exchange commissionCompany consumer healthConsumer health companyCautionary noteForward looking statementsPrivate securities litigation reform actConsumer healthNew consumer health companyAnnual reportNote regarding forward lookingQuarterly reportsInvestor relations

Johnson & Johnson : FINAL - JNJ Earnings Presentation Q2 2023

1 2nd Quarter 2023 Earnings Call July 20, 2023 Cautionary Note on Forward-looking.

Exchange commissionCompany consumer healthConsumer health companyCautionary noteForward looking statementsPrivate securities litigation reform actConsumer healthNew consumer health companyAnnual reportNote regarding forward lookingQuarterly reportsInvestor relations

Johnson & Johnson Reports Q2 2023 Results

2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5% and adjusted operational growth of 6.2% . Operational growth excluding COVID-19 Vaccine of.

United statesJoaquin duatoBiosense websterKenvue incWomen healthCompany consumer healthLibrexia programConsumer health companyInterventional solutionsExchange commissionReceptor antagonist peptide in developmentConsumer healthSkin health beautyJohnson announces launch of kenvue incChief executivePulmonary hypertension

Johnson & Johnson : FINAL - JNJ Earnings Presentation Q1 2023

1st Quarter 2023 Earnings Call April 18, 2023 Cautionary Note on Forward-looking Statements . | April 18, 2023

Exchange commissionConsumer health companyCompany consumer healthCautionary noteForward looking statementsPrivate securities litigation reform actConsumer healthNew consumer health companyAnnual reportNote regarding forward lookingQuarterly reportsInvestor relationsJohnson stock exchangePress releaseN jnj us4781601046

vimarsana © 2020. All Rights Reserved.